This inventor holds 1 USPTO granted patent. Top assignee: Abcellera Biologics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lindsay Devorkin’s Patent Work in Biotherapeutics.
Introduction
Lindsay Devorkin is an inventor based in Vancouver, Canada, associated with AbCellera Biologics Inc. His patent work includes an invention concerning CD3 T-cell engagers, a class of molecules designed to direct T cells toward target cells.
Latest Patents
Devorkin is listed as an inventor on one patent, titled “CD3 T-Cell Engagers and Methods of Use.” The patent describes T-cell engager technology and methods for its application. 1 patent
Career Highlights
Devorkin’s listed patent activity is connected to AbCellera Biologics Inc., a biotechnology company. The available information identifies his contribution in the area of T-cell engager inventions.
Collaborations
The patent’s listed collaborators include Aaron Paul Yamniuk and Bryan Crawford Barnhart. Their shared work reflects collaboration on the CD3 T-cell engager invention.
Conclusion
Lindsay Devorkin’s patent record highlights his contribution to T-cell engager technology through an invention developed in collaboration with colleagues at AbCellera Biologics Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile